USPTO serial 79298902
BIOCOPY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 28, 2021
- Examiner
- SCLEIDOROVICH, JOANNA YAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with BIOCOPY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological inoculants, other than for medical use; inoculants, other than for medical or veterinary use; proteins for use in recombinant DNA technology, other than for medical use; proteins for industrial use; proteins for use in science; proteins for binding antibodies, other than for medical use; proteins for detecting antibodies, other than for medical use; regulatory proteins for industrial use; regulatory proteins for scientific use | ACTIVE | — |
| 005 | Chemical preparations for use in DNA analysis, namely, preparations for diagnosing bacterial or viral diseases, metabolic disorders or cancer for medical purposes; reagents for use in analysis, namely, veterinary diagnostic reagents; reagents for analytical purposes, namely, reagents for medical purposes; chemical, diagnostic reagents for analytical and veterinary purposes; reagents for microbiological analysis, for medical purposes; reagents for microbiological analysis, for veterinary purposes; reagents for use in analysis of biomolecule samples, for medical purposes; reagents for use with analyzers, for veterinary purposes; reagents for use with analyzers, for medical purposes; vaccines; diagnostic biomarker reagents for medical purposes | ACTIVE | — |
| 009 | Apparatus for scientific research and laboratories, namely, reflectometers; recorded content in the nature of software for analyzing biomolecule sequences; information technology and audio-visual, multimedia and photographic devices, namely, molecule detection systems; measuring, detecting and monitoring instruments, indicators and controllers; DNA chips; DNA microarray; microarray slides being laboratory equipment; microscope slides being laboratory equipment; biochips for research or scientific purposes; bio-sensors being sensors for use in biomolecular measurement; Downloadable software for use in the field of bioinformatics | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research and analysis in the field of biomolecule copying and analysis; Product testing and quality control for others; Authentication, namely, Providing user authentication services using single sign-on technology for online software applications; provision of information and data relating to medical and veterinary research and development; providing information about industrial analysis and research services in the field of biomolecule copying; biochemical analysis; biochemical research and analysis; biological analysis; biological research and analysis; blood analysis services for scientific research purposes; analytical laboratory service for medical purposes; Product development for other, namely, development of coatings for non-metals; research and development of vaccines and medicines; research and development services in the field of antibody technology; research and development services relating to vaccines; research and development services in the field of antibodies; information technology consulting services for the pharmaceutical and healthcare industries; laboratory services relating to the production of monoclonal antibodies; scientific analysis, namely, biomolecule analysis services for scientific research purposes; scientific research and analysis in the field of biomolecule copying | ACTIVE | — |
| 044 | Medical consultancy and information services relating to pharmaceutical products; medical consultancy and information services relating to biopharmaceutical products; medical consultancy and information services relating to medical products; DNA screening for medical purposes; Medical analysis services, namely, RNA and DNA analysis for cancer diagnosis and prognosis; Medical analysis services, namely, laboratory analysis services relating to the treatment of persons; Medical analysis services, namely, laboratory analysis services relating to the treatment of animals; medical analysis services relating to the treatment of persons; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic services; medical and health assessment services relating to DNA, genetics and genetic testing; medical advisory, consultancy and information services relating to the development and detection of vaccines | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BioCopy GmbH
- Other trademarks owned by BioCopy GmbH
- Other trademarks owned by BioCopy GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BIOCOPY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 4, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 16, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 16, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 28, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 28, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 19, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 13, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 13, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 30, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 30, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 23, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 4, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 3, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 3, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 3, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 5, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 4, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 12, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 12, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 8, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 5, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 4, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 4, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 4, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 3, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |